Detection of Phosphorylated NF-H in the Cerebrospinal Fluid and Blood of Aneurysmal Subarachnoid Hemorrhage Patients
Overview
Endocrinology
Neurology
Affiliations
Blood and cerebrospinal fluid (CSF) of 30 Fisher grade 3 aneurysmal subarachnoid hemorrhage (ASAH) patients were analyzed for the presence of the phosphorylated axonal form of the major neurofilament subunit NF-H (pNF-H), a promising biomarker of axonal injury. Patient demographic data including development of vasospasm and outcome scores at 6 months after aneurysmal rupture (AR) were evaluated. Higher pNF-H blood levels in the first few days after AR were strongly predictive of a negative outcome. Blood pNF-H levels in most recovering patients showed a steady increase into the second week after AR, presumably reflecting axonal degeneration secondary to the original insult. Almost half of the patients studied showed sudden dramatic peaks of pNF-H protein release into CSF in the 3- to 14-day time period after AR, which must reflect profound, coordinated, and secondary loss of axons. Patients in whom vasospasm was detected had significantly more pNF-H in both blood and CSF compared with those in whom vasospasm was not detected. We conclude that the analysis of pNF-H levels in blood and CSF differentiates between patients with poor and favorable outcomes and also reveals several novel features of ASAH progression and recovery.
Santana D, Llull L, Mosteiro A, Pedrosa L, Pujol G, Zattera L Mol Neurobiol. 2024; 62(2):1467-1477.
PMID: 38992213 PMC: 11772382. DOI: 10.1007/s12035-024-04347-6.
Serum neurofilament light as a predictor of outcome in subarachnoid haemorrhage.
Johansson C, Aineskog H, Koskinen L, Gunnarsson A, Lindvall P Acta Neurochir (Wien). 2023; 165(10):2793-2800.
PMID: 37351672 PMC: 10542720. DOI: 10.1007/s00701-023-05673-9.
Slovinska L, Harvanova D, Janockova J, Matejova J, Cibur P, Moravek M Curr Issues Mol Biol. 2022; 44(2):578-596.
PMID: 35723326 PMC: 8929137. DOI: 10.3390/cimb44020040.
van den Bosch A, Fransen N, Mason M, Rozemuller A, Teunissen C, Smolders J Neurol Neuroimmunol Neuroinflamm. 2022; 9(3).
PMID: 35241571 PMC: 8893592. DOI: 10.1212/NXI.0000000000001154.
Neurofilament Proteins as Biomarkers to Monitor Neurological Diseases and the Efficacy of Therapies.
Yuan A, Nixon R Front Neurosci. 2021; 15:689938.
PMID: 34646114 PMC: 8503617. DOI: 10.3389/fnins.2021.689938.